Search
  • Site Search
  • News
  • Product

    • Zhejiang Medical Technology Development Co., Ltd.

    Novartis guests lectured on compliance rules to facilitate academic promotion of Hycamtin
    On April 9, 2018, the guests from Novartis came to the meeting room of the Hangzhou headquarters of Winhealth Group. In order to better promote Hycamtin®, the Compliance Department invited Shirley Zhang, compliance director of Novartis Sandoz, and Wang Li, brand group manager, to Winhealth Group to lecture on Novartis's compliance rules for our staff. Relevant regional managers and medical information representatives from the Central and Southern Region came to the meeting room early in the morning. They came from Hangzhou, Ningbo and Wuhan respectively to receive face-to-face tr...
    Novartis guests lectured on compliance rules to facilitate academic promotion of Hycamtin
    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end
    On March 15-17, the 2018 China Summit for NASDAQ Innovative Pharmaceutical Enterprises and Hangzhou CBD Investment Forum, which was co-hosted by Winhealth Group, was successfully concluded at InterContinental Hotel in Hangzhou.This summit was specially hosted by Hangzhou Xiacheng District People's Government, hosted by TPP Medical Company (U.S.), and jointly organized by Winhealth Group and Xiacheng District State-owned Investment Holding Group. It is the first large-scale exchange activity for the European and American enterprises and Nasdaq listed companies currently held by the domestic...
    Winhealth worked with hundreds pharmaceutical enterprises 2018CHIPS Summit came to a successful end
    Training session on Mucosolvan Injection of Winhealth Group successfully held
    From January 18 to January 19, 2018, a two-day Mucosolvan Injection training session was held in the meeting room on the second floor of the company, and we were very honored to invite the team of Boehringer Ingelheim (hereinafter referred to as 'BI') to the scene. In this training session, BI and Zhejiang Medical jointly exchanged and shared medical knowledge, relevant skills and valuable experience related to Mucosolvan Injection. On the first day of the training, the representatives of the BI team made opening remarks first. After that, BI and the leaders and representatives of...
    Training session on Mucosolvan Injection of Winhealth Group successfully held
    Ipsen China and Zhejiang Medical announced conclusion of strategic cooperation agreement
    (Hangzhou, Zhejiang, China)-On December 12, 2017, Bofu-Ipsen (Tianjin) Pharmaceutical Co., Ltd. (hereinafter referred to as 'Ipsen China') and Zhejiang Medical Technology Development Co., Ltd. (hereinafter referred to as 'Zhejiang Medical') announced today that they had formally concluded a strategic cooperation agreement to promote Tanakan® in the Chinese market. This strategic cooperation is the beginning of mutual complementarity, information sharing and mutual benefit. With the signing of the strategic cooperation agreement, the two sides will further expand ...
    Ipsen China and Zhejiang Medical announced conclusion of strategic cooperation agreement
    Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. Established Strateg
    (November 2, 2017, Shanghai) Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. announced that they had concluded a strategic partnership agreement. Boehringer-Ingelheim China will grant exclusive authorization for the marketing of its respiratory drug Mucosolvan® injection to Zhejiang Medical Technology  Development Co., Ltd. (hereinafter Zhejiang Medical) from January 1, 2018. Boehringer-Ingelheim is still the owner and producer of Mucosolvan® injection.“We are very glad to establish strategic partnership with Zhejiang Medical....
    Boehringer-Ingelheim China and Zhejiang Medical Technology Development Co., Ltd. Established Strateg
    Congratulate Zhejiang Zhejiang Medical Technology Development Co., Ltd. Becoming the Exclusive Agent
    Congratulate Zhejiang Medical Technology Development Co., Ltd. signing an agreement with Merz Germany. On October 27, 2017, Zhejiang Medical Technology Development Co., Ltd. and Merz Germany held an agreement signing ceremony for Contractubex in Wuxi, Jiangsu. Zhejiang Medical has officially become the exclusive agent of Contractubex in China.Contractubex® is the most popular scar treatment medicine around the world.Contractubex® has successfully been used to treat scars for more than 50 years. It is the scar treatment medicine sold best in over 60 countries and o...
    Congratulate Zhejiang Zhejiang Medical Technology Development Co., Ltd. Becoming the Exclusive Agent
    Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth
    On June 5, Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth Health Industrial Park in Xiacheng District, accompanied by the main leaders of the District Government Office, District Development and Reform Bureau, District Finance Bureau, District Health Planning Bureau, District Market Supervision Bureau, and Zhaohui Street Committee. Chai and his entourage first visited the functional areas of Winhealth Health Industrial Park, learned about the current industrial layout and development status of the park, then held a symposium to listen to a report made by the head o...
    Chai Shimin, head of Xiacheng District, and his entourage visited Winhealth
    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.
      网站地图
    浙ICP备12044547号
    Sitemap
    浙公网安备 33010302003458号